Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation

Direct oral anticoagulants (DOACs) used in nonvalvular atrial fibrillation (NVAF) are dose-reduced in elderly and patients with impaired renal function. Only reduced dose dabigatran is concluded as having similar stroke risk reduction and lower risk of major bleeding than warfarin in the pivotal stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Jansson, M., Själander, S., Sjögren, V., Björck, F., Renlund, H., Norrving, B., Själander, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110706/
https://www.ncbi.nlm.nih.gov/pubmed/36607464
http://dx.doi.org/10.1007/s11239-022-02763-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110706/
https://www.ncbi.nlm.nih.gov/pubmed/36607464
http://dx.doi.org/10.1007/s11239-022-02763-w

Ejemplares similares